Results 181 to 190 of about 5,580 (262)

Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease. [PDF]

Eur Radiol
Wassenaar NPM, van Son KC, Voermans B, van Eekhout KMA, Troelstra MA, Driessen S, Mak AL, Witjes JJ, van Dijk AM, Houttu V, Zwirs D, Shumbayawonda E, Nieuwdorp M, Doukas M, Verheij J, Nederveen AJ, Gurney-Champion OJ, Holleboom AG.   +17 more
europepmc   +1 more source

Pediatric Phthiriasis Palpebrarum: A French Multicentric Retrospective Study of 20 Cases. [PDF]

J Pediatr Clin Pract
Damez M, Welfringer A, Leaute-Labreze C, Chiaverini C, Mallet S, Tardieu M, Jegou MH, Mahe E, Maruani A, Misery L, Abasq-Thomas C, Groupe de Recherche de la Société Française de Dermatologie Pédiatrique.   +11 more
europepmc   +1 more source

Issue Information

Experimental Physiology, Volume 111, Issue 11, Page 5267-5271, 1 November 2026.
wiley   +1 more source

MRI in MASLD: technical foundations and guideline-based applications. [PDF]

BMJ Open Gastroenterol
Pu J, Zhu L, Wu Y, Ping F, Xu J, Zhou K, Wang X, Pan J.   +7 more
europepmc   +1 more source

Letter on 'Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution'. Authors' Reply. [PDF]

Aliment Pharmacol Ther
Souza M, Huang DQ, Loomba R.
europepmc   +1 more source

Electronic patient-reported outcomes for outpatient care after non-intubated thoracic surgery in early-stage lung cancer. [PDF]

J Thorac Dis
Xie S, Li M, Li R, Chen Y, Guo W, Huang D.   +5 more
europepmc   +1 more source

Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review. [PDF]

Liver Int
van Eekhout KMA, Broekman LD, de Jong VD, Michel M, Grobbee R, Maya-Miles D, Romero-Gómez M, Muris J, Mendive JM, Vali Y, Franco OH, Schattenberg JM, Fournier-Poizat C, Castro Cabezas M, Tushuizen ME, Holleboom AG, GRIPonMASH consortium.   +16 more
europepmc   +1 more source

Liver Biopsy in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: Potential Pitfalls and Solutions. [PDF]

Liver Int
Lawitz EJ, Poordad F, Goodman ZD.
europepmc   +1 more source

Progression of Metabolic Dysfunction-Associated Steatohepatitis in US Adults Using Linked Records and Claims. [PDF]

Gastro Hep Adv
Kim Y, Fakhraei R, O'Donnell JC, Johnston K, Bather M, Mustafa R, Kennedy AR, Dinani A.   +7 more
europepmc   +1 more source